NeoStem, Inc. Announces Geographic Expansion of Intellectual Property Coverage of Cardiovascular Asset AMR-001
5/16/2013 9:11:17 AM
More...
|
NeoStem, Inc. to Present at Multiple Conferences in May
5/14/2013 9:10:55 AM
More...
|
NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, to Provide Autologous and Allogeneic Cellular Therapy Services to MedStar Georgetown University Hospital
5/13/2013 9:52:00 AM
More...
|
NeoStem, Inc. CEO's Letter to Shareholders
5/10/2013 11:23:46 AM
More...
|
NeoStem, Inc. Clarification: No New Securities Being Issued
5/10/2013 9:41:16 AM
More...
|
NeoStem, Inc. Announces Partial Exercise of Underwriters' Over-Allotment Option
5/1/2013 1:21:39 PM
More...
|
NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, Enters Into a Services Agreement With Sentien Biotechnologies, Inc.
4/29/2013 11:31:02 AM
More...
|
NeoStem, Inc. to Present at Multiple Conferences in April
4/1/2013 10:22:05 AM
More...
|
NeoStem, Inc. Awarded Second Year of National Institute of Allergy And Infectious Diseases (NIAID) Research Grant for the Development of VSEL Technology for Radiation Exposure
3/28/2013 10:34:29 AM
More...
|
NeoStem, Inc. Announces Intellectual Property Expansion in Cardiovascular Disease
3/13/2013 11:27:34 AM
More...
|
|